Factors affecting tuberculosis retreatment defaults in Nanded, India

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 41, Issue 5, 2010, Pages 1153-1157

  Bhagat, Vijay Manohar ^a   Gattani, Prakash Laxminarayan ^b  

^a Raichur Institute of Medical Sciences   (India)

^b GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Compliance; Factors; Retreatment; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; HUMAN; INDIA; INTERVIEW; MIDDLE AGED; PATIENT COMPLIANCE; RISK FACTOR; TREATMENT OUTCOME; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; HUMANS; INDIA; INTERVIEWS AS TOPIC; MEDICATION ADHERENCE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 79952108756     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Abate G, Miorner H, Ahmed O, Hoffner SE. Drug resistance in Mycobacterium tuberculosis strains isolated from retreatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs. Int J Tuberc Lung Dis 1998; 2: 580-4.
2. Agarwal SP. New challenges in implementation of RNTCP in India. Ind J Tuberc 2005; 52: 1-4.
3. Burman WJ, Cohn DL, Rietmeyer CA, Judson FN, Sharbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of the treatment. Chest 1997; 111: 1151-3.
4. Burman WJ. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. Managing the revised national TB control programme in your area. Training Module 1-10. New Delhi: Ministry of Health and Family Welfare, April 2005.
5. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. TB India 2008: RNTCP status report. New Delhi: Ministry of Health and Familay Welfare, March 2008.
6. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. TB India 2006 RNTCP status report. New Delhi: Ministry of Health and Family Welfare, February 2006.
7. Espinal MA, Laserson K, Camacho M, et al. Determinants of drug resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001; 5: 887.
8. Kuadan C, Bercion R, Jifon G, et al. Acquired anti-TB drugs resistance in Yaounde, Cameroon, Int J Tuberc Lung Dis 2000; 4: 427.
9. Liefooghe R, Suetens C, Meulemans H, Moran MB, De Muynck A. A randomised trial of the impact of counselling on treatment adherence of tuberculosis patients in Sialkot, Pakistan. Int J Tuberc Lung Dis 1999; 3: 1073-80.
10. Ottmani SE, Zignol M, Bencheikh N, Laâsri L, Chaouki N, Mahjour J. Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003. Int J Tuberc Lung Dis 2006; 10: 1367-72.
11. Sophai V, Balasangameshwara VH, Jagannatha PS, Saroja VN, Shivashankar B, Jagota P. Retreatment outcome of smear positive tuberculosis cases under DOTS in Bangalore City. Ind J Tuberc 2002; 49: 195-204.
12. Sophai V, Balasangameswara VH, Jagannatha PS, Saroja VN, Kumar P. Defaults among tuberculosis patients treated under DOTS in Bangalore City: A search for solution. Ind J Tuberc 2003; 50: 185-95.
13. Tuberculosis Research Centre. Low rates of emergence of drug resistance in sputum positive patients treated with SCC. Int J Tuberc Lung Dis 2001; 5: 42.
14. World Health Organization (WHO). Towards a TB free future. Geneva: WHO 2001.